The struggling biotech firm, NovaGen Therapeutics, faced significant fiscal difficulties stemming from disappointing clinical trials and mounting debt. Their internal leadership lacked the expertise to manage https://phoebeqixo234469.blog-gold.com/58470193/biotech-cfo-services-a-case-study-in-monetary-turnaround